Battelle’s ThreatSEQ™ Service Wins Prestigious R&D 100 Award in 56th Annual Competition
Summary
COLUMBUS, Ohio--( BUSINESS WIRE )--A Battelle -developed technology that builds on more than a decade of biodefense expertise and genomic data collection and analysis has been named a recipient of a 2018 R&D 100 Award and further enhances Battelle’s position at the forefront of innovation for biosecurity.Due to the dual-use nature of emerging biotechnology, biosecurity is a necessary component of the industry, particularly for the gene synthesis sector which produces DNA sequences to order.“It’s always an honor to be among this group of award-winning technologies that have far-reaching impact, and the potential to change our world for the better,” said Battelle President and CEO Lou Von Thaer.At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers.Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries.